CONCEPT MEDICAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN "MAGICAL-ISR" IDE STUDY IN THE US
TAMPA, Fla., April 20, 2024 /PRNewswire/ -- Concept Medical, a pioneer in innovative drug delivery technologies, proudly announces the commencement of its groundbreaking IDE clinical study, "MAGICAL-ISR" using MagicTouch – Sirolimus drug coated balloon (DCB), for the management of in-stent restenosis (ISR) in coronary artery disease. MagicTouch in ISR indication, had earlier been granted a 'Breakthrough Device' designation& later the Investigational Device Exemption (IDE)approval
April 20, 2024